Report

src

Global Prostate Cancer Diagnostics Market by Product Type (Preliminary Tests, PSA Testing, Digital Rectal Exam, Biomarker Tests, Confirmatory Tests, PCA3 Test, Trans-rectal Ultrasound and Biopsy) and by End-Users/Application (Hospitals & clinics, Diagnostic Laboratories, Cancer Research Institutes and Others) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2020 - 2027

 Report Code
 Category
 Published Date
 Pages
 Format
MNR-1363
Healthcare
09 June 2020
207
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

The report on the global prostate cancer diagnostics market analyzes complete scenario i.e., existing as well as future visions of prostate cancer diagnostics market. It includes detailed overview of prostate cancer diagnostics market along with market pictures. Additionally, report has included complete data of the various segments in the global prostate cancer diagnostics market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global prostate cancer diagnostics market report offers in-depth insights, revenue details, and other vital information regarding the global prostate cancer diagnostics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2026. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of prostate cancer diagnostics market.

Market Segmentation:
Segmentation by Type Preliminary Tests
PSA Testing
Digital Rectal Exam
Biomarker Tests
Confirmatory Tests
PCA3 Test
Trans-rectal Ultrasound
Biopsy
Segmentation by Application Hospital & Clinics
Diagnostic Laboratories
Cancer Research Institutes
Others
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, prostate cancer diagnostics market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global prostate cancer diagnostics market. It projects the market assessment for the predicted time. Along with all this report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global Prostate Cancer Diagnostics Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each prostate cancer diagnostics market player.
  • Region-wise and country-wise breakdown of the prostate cancer diagnostics market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global prostate cancer diagnostics market.
  • Year-on-year growth of the global prostate cancer diagnostics market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand-new proposition to embellish prostate cancer diagnostics market and nurture business as it explains current global market as well as future market.

Chapter 1 Prostate Cancer Diagnostics Market Overview
1.1 Product Overview and Scope of Prostate Cancer Diagnostics

Chapter 2 Impact of COVID 19
2.1 Impact on Industry
2.2 Impact on Prostate Cancer Diagnostics market
2.3 Consumer Buying Behavior based on Prostate Cancer Diagnostics Market
2.4 Recovery and forecast Analysis based on Prostate Cancer Diagnostics Market

Chapter 3 Executive Summary 
3.1 Drivers for Prostate Cancer Diagnostics Market: 
3.2 Restrain for Prostate Cancer Diagnostics Market:
3.3 Opportunity for Prostate Cancer Diagnostics Market: 
3.4 Global Prostate Cancer Diagnostics market, 2015 - 2027
3.5 Global Prostate Cancer Diagnostics market, by Region, 2015 - 2027
3.6 Global Prostate Cancer Diagnostics market, by Type, 2015 - 2027
3.7 Global Prostate Cancer Diagnostics market, by Application, 2015 - 2027

Chapter 4 Prostate Cancer Diagnostics Segment by Types (Product Category) 
4.1 Global Prostate Cancer Diagnostics Revenue (USD Billion) and Growth Rate (%) Comparison by Types (2015-2020) 
4.2 Global Prostate Cancer Diagnostics Revenue Market Share (%) by Types in 2019
4.3 Preliminary Tests
4.4 PSA Testing
4.5 Digital Rectal Exam
4.6 Biomarker Tests
4.7 Confirmatory Tests
4.8 PCA3 Test
4.9 Trans-rectal Ultrasound
4.10 Biopsy

Chapter 5 Global Prostate Cancer Diagnostics Segment by Application 
5.1 Global Prostate Cancer Diagnostics Revenue (USD Billion) Comparison by Application (2015-2027) 
5.2 Hospital & Clinics
5.3 Diagnostic Laboratories
5.4 Cancer Research Institutes
5.5 Others 

Chapter 6 Global Prostate Cancer Diagnostics Market by Regions (2015-2027) 
6.1 Global Prostate Cancer Diagnostics Market Size and Growth Rate (%) Comparison by Regions (2015-2027) 
6.2 North America Prostate Cancer Diagnostics Status and Prospect (2015-2027) 
6.3 Europe Prostate Cancer Diagnostics Status and Prospect (2015-2027) 
6.4 Asia Pacific Prostate Cancer Diagnostics Status and Prospect (2015-2027) 
6.5 South America Prostate Cancer Diagnostics Status and Prospect (2015-2027) 
6.6 Middle East & Africa Prostate Cancer Diagnostics Status and Prospect (2015-2027) 
6.7 Global Prostate Cancer Diagnostics Market Size (2015-2027) 
            6.7.1 Global Prostate Cancer Diagnostics Revenue Status and Outlook (2015-2027) 
            
Chapter 7 PESTEL Analysis
7.1 Political Factors
7.2 Economic Factors
7.3 Social Factors
7.4 Technological Factors
7.5 Legal Factors
7.6 Environment Factors

Chapter 8 Global Prostate Cancer Diagnostics Market Competition by Manufacturers
8.1 Global Prostate Cancer Diagnostics Revenue and Share by Manufacturers (2015-2019) 

Chapter 9 Company (Top Players) Profiles and Key Data
9.1 Abbvie Inc.
            9.1.1 Company Basic Information and Sales Area
            9.1.2 Business Segment/ Overview
            9.1.3 Investment in Research and Development
            9.1.4 Prostate Cancer Diagnostics Product Types Specification
            9.1.5 Key Developments
            9.1.6 Business Strategy
9.2 Dendreon Pharmaceuticals LLC
            9.2.1 Company Basic Information and Sales Area
            9.2.2 Business Segment/ Overview
            9.2.3 Investment in Research and Development
            9.2.4 Prostate Cancer Diagnostics Product Types Specification
            9.2.5 Business Strategy
9.3 Astra Zeneca
            9.3.1 Company Basic Information and Sales Area
            9.3.2 Business Segment/ Overview
            9.3.3 Prostate Cancer Diagnostics Product Types Specification
            9.3.4 Key Developments
            9.3.5 Business Strategy
9.4 Bayer AG
            9.4.1 Company Basic Information and Sales Area. 
            9.4.2 Business Segment/ Overview
            9.4.3 Prostate Cancer Diagnostics Product Types Specification
            9.4.4 Business Strategy
9.5 MDx Health
            9.5.1 Company Basic Information and Sales Area. 
            9.5.2 Business Segment/ Overview
            9.5.3 Prostate Cancer Diagnostics Product Types Specification
            9.5.4 Business Strategy
9.6 Myriad Genetics, Inc.
            9.6.1 Company Basic Information and Sales Area
            9.6.2 Business Segment/ Overview
            9.6.3 Prostate Cancer Diagnostics Product Types Specification
            9.6.4 Business Strategy
9.7 Abbott Laboratories
            9.7.1 Company Basic Information and Sales Area
            9.7.2 Business Segment/ Overview
            9.7.3 Investment in Research and Development
            9.7.4 Prostate Cancer Diagnostics Product Types Specification
            9.7.5 Key Developments
            9.7.6 Business Strategy
9.8 F. Hoffman-La Roche AG
            9.8.1 Company Basic Information and Sales Area. 
            9.8.2 Business Segment/ Overview
            9.8.3 Prostate Cancer Diagnostics Product Types Specification
            9.8.4 Business Strategy
9.9 Siemens Healthineers AG
            9.9.1 Company Basic Information and Sales Area
            9.9.2 Business Segment/ Overview
            9.9.3 Prostate Cancer Diagnostics Product Types Specification
            9.9.4 Business Strategy
9.10 Johnson & Johnson Services Inc.
            9.10.1 Company Basic Information and Sales Area
            9.10.2 Business Segment/ Overview
            9.10.3 Prostate Cancer Diagnostics Product Types Specification
            9.10.4 Business Strategy
            
Chapter 10 Global Prostate Cancer Diagnostics Revenue by Regions (2015-2020) 
10.1 Global Prostate Cancer Diagnostics Revenue and Market Share (%) by Regions (2015-2020) 

Chapter 11 Global Prostate Cancer Diagnostics Revenue by Types
11.1 Global Prostate Cancer Diagnostics Revenue and Market Share (%) by Types (2015-2020) 

Chapter 12 Global Prostate Cancer Diagnostics Market Analysis by Application
12.1 Global Prostate Cancer Diagnostics Revenue (USD Billion) and Market Share (%) by Application (2015-2020) 
12.2 Global Prostate Cancer Diagnostics Revenue Growth Rate by Application (2015-2020) 

Chapter 13 North America Prostate Cancer Diagnostics Market Development Status and Outlook
13.1 North America Prostate Cancer Diagnostics Market Size (2015-2020) 
            13.1.1 North America Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2015-2020) 
13.2 North America Prostate Cancer Diagnostics Market Size (2015-2020) 
            13.2.1 North America Prostate Cancer Diagnostics Market Size by Application (USD Billion) (2015-2020) 
13.3 U.S
            13.3.1 U.S. Prostate Cancer Diagnostics market, by Type, 2015 - 2027
            13.3.2 U.S. Prostate Cancer Diagnostics market, by Application, 2015 – 2027
13.4 Canada
            13.4.1 Canada Prostate Cancer Diagnostics market, by Type, 2015 - 2027
            13.4.2 Canada Prostate Cancer Diagnostics market, by Application, 2015 – 2027
13.5 Mexico
            13.5.1 Mexico Prostate Cancer Diagnostics market, by Type, 2015 - 2027
            13.5.2 Mexico Prostate Cancer Diagnostics market, by Application, 2015 – 2027
            
Chapter 14 Europe Prostate Cancer Diagnostics Market Development Status and Outlook
14.1 Europe Prostate Cancer Diagnostics Market Size (2015-2020) 
            14.1.1 Europe Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2015-2020) 
14.2 Europe Prostate Cancer Diagnostics Market Size (2015-2020) 
            14.2.1 Europe Prostate Cancer Diagnostics Market Size by Application (USD Billion) (2015-2020) 
14.3 U.K.
            14.3.1 U.K. Prostate Cancer Diagnostics market, by Type, 2015 - 2027
            14.3.2 U.K. Prostate Cancer Diagnostics market, by Application, 2015 – 2027
14.4 Germany
            14.4.1 Germany Prostate Cancer Diagnostics market, by Type, 2015 - 2027
            14.4.2 Germany Prostate Cancer Diagnostics market, by Application, 2015 – 2027
14.5 France
            14.5.1 France Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            14.5.2 France Prostate Cancer Diagnostics market, by Application, 2015 – 2027
14.6 Italy
            14.6.1 Italy Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            14.6.2 Italy Prostate Cancer Diagnostics market, by Application, 2015 – 2027
14.7 Spain
            14.7.1 Spain Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            14.7.2 Spain Prostate Cancer Diagnostics market, by Application, 2015 – 2027
14.8 Rest of Europe
            14.8.1 Rest of Europe Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            14.8.2 Rest of Europe Prostate Cancer Diagnostics market, by Application, 2015 – 2027
            
Chapter 15 Asia Pacific Prostate Cancer Diagnostics Market Development Status and Outlook
15.1 Asia Pacific Prostate Cancer Diagnostics Market Size (2015-2020) 
            15.1.1 Asia Pacific Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2015-2020) 
15.2 Asia Pacific Prostate Cancer Diagnostics Market Size (2015-2020) 
            15.2.1 Asia Pacific Prostate Cancer Diagnostics Market Size by Application (USD Billion) (2015-2020) 
15.3 China
            15.3.1 China Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            15.3.2 China Prostate Cancer Diagnostics market, by Application, 2015 – 2027
15.4 Japan
            15.4.1 Japan Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            15.4.2 Japan Prostate Cancer Diagnostics market, by Application, 2015 – 2027
15.5 India
            15.5.1 India Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            15.5.2 India Prostate Cancer Diagnostics market, by Application, 2015 – 2027
15.6 Southeast Asia
            15.6.1 Southeast Asia Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            15.6.2 Southeast Asia Prostate Cancer Diagnostics market, by Application, 2015 – 2027
            
Chapter 16 South America Prostate Cancer Diagnostics Market Development Status and Outlook
16.1 South America Prostate Cancer Diagnostics Market Size (2015-2020) 
            16.1.1 South America Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2015-2020) 
16.2 South America Prostate Cancer Diagnostics Market Size (2015-2020) 
            16.2.1 South America Prostate Cancer Diagnostics Market Size by Application (USD Billion) (2015-2020) 
16.3 Brazil
            16.3.1 Brazil Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            16.3.2 Brazil Prostate Cancer Diagnostics market, by Application, 2015 – 2027 
16.4 Argentina
            16.4.1 Argentina Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            16.4.2 Argentina Prostate Cancer Diagnostics market, by Application, 2015 – 2027 
16.5 Colombia
            16.5.1 Colombia Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            16.5.2 Colombia Prostate Cancer Diagnostics market, by Application, 2015 – 2027
16.6 Rest of South America
            16.6.1 Colombia Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            16.6.2 Colombia Prostate Cancer Diagnostics market, by Application, 2015 – 2027
            
Chapter 17 Middle East & Africa Prostate Cancer Diagnostics Market Development Status and Outlook
17.1 Middle East & Africa Prostate Cancer Diagnostics Market Size (2015-2020) 
            17.1.1 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2015-2020) 
17.2 Middle East & Africa Prostate Cancer Diagnostics Market Size (2015-2020) 
            17.2.1 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2015-2020) 
17.3 UAE
            17.3.1 UAE Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            17.3.2 UAE Prostate Cancer Diagnostics market, by Application, 2015 – 2027
17.4 South Africa
            17.4.1 South Africa Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            17.4.2 South Africa Prostate Cancer Diagnostics market, by Application, 2015 – 2027
17.5 Egypt
            17.5.1 Egypt Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            17.5.2 Egypt Prostate Cancer Diagnostics market, by Application, 2015 – 2027
17.6 Rest of MEA
            17.6.1 Rest of MEA Prostate Cancer Diagnostics market, by Type, 2015 – 2027
            17.6.2 Rest of MEA Prostate Cancer Diagnostics market, by Application, 2015 – 2027
            
Chapter 18 Prostate Cancer Diagnostics Manufacturing Cost Analysis
18.1 Proportion of Manufacturing Cost Structure
            18.1.1 Raw Materials
            18.1.2 Labor Cost
            18.1.3 USA Labor Cost Analysis
            18.1.4 EU Labor Costs Analysis
            18.1.5 China Labor Costs Analysis
            18.1.6 Manufacturing Expenses
            
Chapter 19 Marketing Strategy Analysis, Distributors/ Traders
19.1 Marketing Channel
            19.1.1 Direct Marketing
            19.1.2 Indirect Marketing
            19.1.3 Marketing Channel Development Trend
19.2 Market Positioning
            19.2.1 Pricing Strategy
            
Chapter 20 Global Prostate Cancer Diagnostics Market Forecast (2020-2027) 
20.1 Global Prostate Cancer Diagnostics Revenue Forecast (2020-2027) 
            20.1.1 Global Prostate Cancer Diagnostics Revenue (USD Billion) and Growth Rate (%) Forecast (2020-2027) 
20.2 Global Prostate Cancer Diagnostics Revenue (USD Billion) Forecast by Regions (2020-2027) 
            20.2.1 North America Prostate Cancer Diagnostics Revenue (USD Billion) Forecast (2020-2027) 
            20.2.2 Europe Prostate Cancer Diagnostics Revenue (USD Billion) Forecast (2020-2027) 
            20.2.3 Asia Pacific Prostate Cancer Diagnostics and Revenue (USD Billion) Forecast (2020-2027) 
            20.2.4 South America Prostate Cancer Diagnostics and Revenue (USD Billion) Forecast (2020-2027) 
            20.2.5 Middle East & Africa Prostate Cancer Diagnostics and Revenue (USD Billion) Forecast (2020-2027) 
20.3 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2020-2027) 
20.4 Global Prostate Cancer Diagnostics Revenue (USD Billion) Forecast by Application (2020-2027)
 
Chapter 21 North America Prostate Cancer Diagnostics Market Development Status and Outlook
21.1 North America Prostate Cancer Diagnostics Market Size (2020-2027) 
            21.1.1 North America Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2020-2027) 
21.2 North America Prostate Cancer Diagnostics Market Size (2020-2027) 
            21.2.1 North America Prostate Cancer Diagnostics Market Size by Application (USD Billion) (2020-2027) 
21.3 U.S.
            21.3.1 U.S. Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            21.3.2 U.S. Prostate Cancer Diagnostics market, by Application, 2020 – 2027
21.4 Canada
            21.4.1 Canada Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            21.4.2 Canada Prostate Cancer Diagnostics market, by Application, 2020 – 2027
21.5 Mexico
            21.5.1 Mexico Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            21.5.2 Mexico Prostate Cancer Diagnostics market, by Application, 2020 – 2027
            
Chapter 22 Europe Prostate Cancer Diagnostics Market Development Status and Outlook
22.1 Europe Prostate Cancer Diagnostics Market Size (2020-2027) 
            22.1.1 Europe Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2020-2027) 
22.2 Europe Prostate Cancer Diagnostics Market Size (2020-2027) 
            22.2.1 Europe Prostate Cancer Diagnostics Market Size by Application (USD Billion) (2020-2027) 
22.3 U.K.
            22.3.1 U.K. Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            22.3.2 U.K. Prostate Cancer Diagnostics market, by Application, 2020 – 2027
22.4 Germany
            22.4.1 Germany Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            22.4.2 Germany Prostate Cancer Diagnostics market, by Application, 2020 – 2027
22.5 France
            22.5.1 France Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            22.5.2 France Prostate Cancer Diagnostics market, by Application, 2020 – 2027
22.6 Italy
            22.6.1 France Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            22.6.2 France Prostate Cancer Diagnostics market, by Application, 2020 – 2027
22.7 Spain
            22.7.1 France Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            22.7.2 France Prostate Cancer Diagnostics market, by Application, 2020 – 2027
22.8 Rest of Europe
            22.8.1 France Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            22.8.2 France Prostate Cancer Diagnostics market, by Application, 2020 – 2027
            
Chapter 23 Asia Pacific Prostate Cancer Diagnostics Market Development Status and Outlook
23.1 Asia Pacific Prostate Cancer Diagnostics Market Size (2020-2027) 
            23.1.1 Asia Pacific Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2020-2027) 
23.2 Asia Pacific Prostate Cancer Diagnostics Market Size (2020-2027) 
            23.2.1 Asia Pacific Prostate Cancer Diagnostics Market Size by Application (USD Billion) (2020-2027) 
23.3 China
            23.3.1 China Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            23.3.2 China Prostate Cancer Diagnostics market, by Application, 2020 – 2027
23.4 Japan
            23.4.1 Japan Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            23.4.2 Japan Prostate Cancer Diagnostics market, by Application, 2020 – 2027
23.5 India
            23.5.1 India Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            23.5.2 India Prostate Cancer Diagnostics market, by Application, 2020 – 2027
23.6 Southeast Asia
            23.6.1 Southeast Asia Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            23.6.2 Southeast Asia Prostate Cancer Diagnostics market, by Application, 2020 – 2027
            
Chapter 24 South America Prostate Cancer Diagnostics Market Development Status and Outlook
24.1 South America Prostate Cancer Diagnostics Market Size (2020-2027) 
            24.1.1 South America Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2020-2027) 
24.2 South America Prostate Cancer Diagnostics Market Size (2020-2027) 
            24.2.1 South America Prostate Cancer Diagnostics Market Size by Application (USD Billion) (2020-2027) 
24.3 Brazil
            24.3.1 Brazil Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            24.3.2 Brazil Prostate Cancer Diagnostics market, by Application, 2020 – 2027 
24.4 Argentina
            24.4.1 Argentina Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            24.4.2 Argentina Prostate Cancer Diagnostics market, by Application, 2020 – 2027 
24.5 Colombia
            24.5.1 Colombia Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            24.5.2 Colombia Prostate Cancer Diagnostics market, by Application, 2020 – 2027
24.6 Rest of South America
            24.6.1 Colombia Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            24.6.2 Colombia Prostate Cancer Diagnostics market, by Application, 2020 – 2027
            
Chapter 25 Middle East & Africa Prostate Cancer Diagnostics Market Development Status and Outlook
25.1 Middle East & Africa Prostate Cancer Diagnostics Market Size (2020-2027) 
            25.1.1 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (USD Billion) (2020-2027) 
25.2 Middle East & Africa Prostate Cancer Diagnostics Market Size (2020-2027) 
            25.2.1 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (USD Billion) (2020-2027) 
25.3 UAE
            25.3.1 UAE Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            25.3.2 UAE Prostate Cancer Diagnostics market, by Application, 2020 – 2027
25.4 South Africa
            25.4.1 South Africa Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            25.4.2 South Africa Prostate Cancer Diagnostics market, by Application, 2020 – 2027
25.5 Egypt
            25.5.1 Egypt Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            25.5.2 Egypt Prostate Cancer Diagnostics market, by Application, 2020 – 2027
25.6 Rest of MEA
            25.6.1 Rest of MEA Prostate Cancer Diagnostics market, by Type, 2020 – 2027
            25.6.2 Rest of MEA Prostate Cancer Diagnostics market, by Application, 2020 – 2027
            
Chapter 26 Research Findings and Conclusion










 

No Methodology

Global Prostate Cancer Diagnostics Market Trends:
The global prostate cancer diagnostics is estimated to be worth USD 2.94 billion in 2019 and is projected to reach USD 7.86 billion by 2027, at a CAGR of 13.8% from 2020 to 2027.

Prostate cancer is a type of cancer developed in the prostate gland (in males), and it spreads into other parts of the body particularly the bones and lymph nodes. And prostate cancer diagnostics is the identification/screening process to detect undiagnosed prostate cancer cells in men that show no symptoms/signs.

Drivers for the Global Prostate Cancer Diagnostics Market:
Rising demand of prostate cancer diagnostics for geriatric population as they have  high prevalence rate of prostate cancer (about 80% of men who reach 80 years of age are diagnosed with it), prostate cancer is known to be second most common type of cancer in males hence it requires diagnosis & treatment, increasing technological advancements of diagnostics techniques that are safe, genetics can pass on the cancer & hence a person with a family history of cancer can diagnose themselves to prevent any growth of cancer cells at an early stage and cancer is a life taking disease hence the diagnostics plays a major role to detect it and help prevent the growth & save lives. Hence these are the major drivers of the market and are owing to increase the growth and disposable income of the market.

Opportunities for the Global Prostate Cancer Diagnostics Market:
Moreover, AI tools are being used using an MRI to detect cancer cells which provide accurate results, increasing health concerns to avoid cancer, government initiatives to encourage new diagnostics devices & technologies that are safe to the body, increasing medical tourism, increasing number of geriatric population, increasing preference towards serum based testing for detecting prostate cancer and introduction of early prostate cancer recognition tools. Hence these factors are going to provide future opportunities for the market.

Restrains for the Global Prostate Cancer Diagnostics Market:
However, complexities associated with prostate cancer diagnostics, high costs for diagnostic procedures, some diagnostic procedures can cause damage to the surrounding cells and risk of other infections during diagnosis of prostate cancer. Hence these factors are going to majorly hamper the growth of the prostate cancer diagnostics market.

Global Prostate Cancer Diagnostics Market, By Type:
Various types are: Preliminary Tests, PSA Testing, Digital Rectal Exam, Biomarker Tests, Confirmatory Tests, PCA3 Test, Trans-rectal Ultrasound and Biopsy. On the basis of type, Preliminary test accounted for largest share of total revenue generated. Because, preliminary tests detect unrecognized/small tumors of cells that have chances to develop or not develop into an advanced stage of cancer, preliminary tests facilitate detection before major symptoms appear hence they are recommended to men who cross the age of 50 & those at a risk of developing the disease and preliminary tests facilitates early diagnostics & treatment of prostate cancer thus increasing survival rate.

Global Prostate Cancer Diagnostics, By Application:
Major applications are: Hospitals & clinics, Diagnostic Laboratories, Cancer Research Institutes and Others. The demand of Global Prostate Cancer Diagnostics Market is highest from hospital & clinics, due to various innovative detection tools that can be available at the hospitals & clinics, increasing number of cancer treatment & detection-oriented hospitals, collaborations between companies & research clinics/hospitals to introduce more innovative techniques for detection & treatment of prostate cancer and high advanced facilities & proper treatment measures available at hospitals.

Global Prostate Cancer Diagnostics market, By Region:
Report covers the region wise analysis, global Prostate Cancer Diagnostics can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, North America held major share in the market due to investment in technology, general economic conditions, high prevalence of the prostrate cancer that require diagnostics, government initiatives to make available early diagnosis, increasing number of hospitals & diagnostic centers, high number of gieratric population and presence of diagnostic manufacturing companies. Besides Europe and Asia-Pacific held a large share in the market.

Major Market Players:
Abbvie Inc., Dendreon Pharmaceuticals LLC, AstraZeneca, Bayer AG, MDx Health; Myriad Genetics, Inc.; Abbott Laboratories; F. Hoffman-La Roche AG; Siemens Healthineers AG; Johnson & Johnson Services Inc., OPKO Health, Inc.; and Genomic Health.

Global Prostate Cancer Diagnostics Market Report Scope:
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Billion)
Covered Segments Product Type, Applications, Geographic Regions
Product Type Preliminary Tests, PSA Testing, Digital Rectal Exam, Biomarker Tests, Confirmatory Tests, PCA3 Test, Trans-rectal Ultrasound and Biopsy
Applications Hospitals & clinics, Diagnostic Laboratories, Cancer Research Institutes and Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Abbvie Inc., Dendreon Pharmaceuticals LLC, AstraZeneca, Bayer AG, MDx Health; Myriad Genetics, Inc.; Abbott Laboratories; F. Hoffman-La Roche AG; Siemens Healthineers AG; Johnson & Johnson Services Inc., OPKO Health, Inc.; and Genomic Health

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global prostate cancer diagnostics market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global Prostate Cancer Diagnostics Market: Product analysis
  • Preliminary Tests
  • PSA Testing
  • Digital Rectal Exam
  • Biomarker Tests
  • Confirmatory Tests
  • PCA3 Test
  • Trans-rectal Ultrasound
  • Biopsy
Global Prostate Cancer Diagnostics Market: Application analysis
  • Hospital & Clinics
  • Diagnostic Laboratories
  • Cancer Research Institutes
  • Others
Market, by regions:
In addition, prostate cancer diagnostics report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase